文献速递眼底病与葡萄膜炎

新型缺氧诱导因子1α抑制剂KC7F2减轻氧诱导视网膜新生血管

A Novel Hypoxia-inducible Factor 1α Inhibitor KC7F2 Attenuates Oxygen-induced Retinal Neovascularization.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

本研究利用C57BL/6J小鼠和Sprague-Dawley大鼠的氧诱导视网膜病变模型,腹腔注射KC7F2后检测视网膜新生血管和炎症,并在体外评估其对VEGF诱导的人脐静脉内皮细胞增殖、迁移和成管的影响。结果显示KC7F2(10 mg/kg/d)减轻病理性新生血管且不改变无血管区,抑制HIF1α-VEGF通路,作者认为其可能成为治疗视网膜新生血管的有效药物。

要点

  • KC7F2(10 mg/kg/d)减轻氧诱导视网膜病变小鼠病理性新生血管并减少视网膜前新生血管细胞核数量。
  • KC7F2(10 mg/kg/d)未改变小鼠视网膜无血管区,在大鼠模型中呈现相同趋势。
  • KC7F2(10 µM)抑制VEGF诱导的人脐静脉内皮细胞增殖、迁移和成管。

核心结论

  • 本研究表明KC7F2可通过HIF1α-VEGF通路有效抑制视网膜新生血管,提示其可能是治疗视网膜新生血管的有效药物。

研究设计与样本

  • 研究采用C57BL/6J小鼠和Sprague-Dawley大鼠的氧诱导视网膜病变模型进行体内实验,并用人脐静脉内皮细胞(HUVEC)进行体外实验。

主要发现

  • 氧诱导视网膜病变小鼠经KC7F2(10 mg/kg/d)治疗后病理性新生血管显著减轻、视网膜前新生血管细胞核数量减少,而无血管区未改变,大鼠模型呈现相同趋势。
  • KC7F2(10 µM)抑制VEGF诱导的HUVEC增殖,与氧诱导视网膜病变小鼠视网膜中观察到的趋势一致。
  • KC7F2抑制VEGF诱导的HUVEC迁移和成管,并降低视网膜新生血管区白细胞和小胶质细胞的共定位密度。
  • 氧诱导视网膜病变小鼠视网膜和缺氧诱导的HUVEC中激活的HIF1α-VEGF通路被KC7F2抑制。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: KC7F2 is a novel molecule compound that can inhibit the translation of hypoxia-inducible factor 1α (HIF1α). It has been reported to exhibit potential antiangiogenic effect. We hypothesized that KC7F2 could inhibit oxygen-induced retinal neovascularization (RNV). The purpose of this study was to investigate this assumption. METHODS: Oxygen-induced retinopathy (OIR) models in C57BL/6J mice and Sprague-Dawley rats were used for in vivo study. After intraperitoneal injections of KC7F2, RNV was detected by immunofluorescence and hematoxylin and eosin staining. Retinal inflammation was explored by immunofluorescence. EdU incorporation assay, cell counting kit-8 assay, scratch test, transwell assay, and Matrigel assay were used to evaluate the effect of KC7F2 on the proliferation, migration and tube formation of human umbilical vein endothelial cells (HUVEC) induced by vascular endothelial growth factor (VEGF) in vitro. Protein expression was examined by Western blot. RESULTS: KC7F2 treatment (10 mg/kg/d) in OIR mice significantly attenuated pathological neovascularization and decreased the number of preretinal neovascular cell nuclei, without changing the avascular area, which showed the same trends in OIR rats. Consistently, after the KC7F2 intervention (10 µM), cell proliferation was inhibited in VEGF-induced HUVEC, which was in agreement with the trend observed in the retinas of OIR mice. Meanwhile, KC7F2 suppressed VEGF-induced HUVEC migration and tube formation, and decreased the density of leukocytes and microglia colocalizing neovascular areas in the retinas. Moreover, the HIF1α-VEGF pathway activated in retinas of OIR mice and hypoxia-induced HUVEC, was suppressed by KC7F2 treatment. CONCLUSIONS: The current study revealed that KC7F2 was able to inhibit RNV effectively via HIF1α-VEGF pathway, suggesting that it might be an effective drug for RNV treatment.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Tang X, Cui K, Lu X, et al. A Novel Hypoxia-inducible Factor 1α Inhibitor KC7F2 Attenuates Oxygen-induced Retinal Neovascularization. Invest Ophthalmol Vis Sci. 2022. PMID: 35695808. doi:10.1167/iovs.63.6.13

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。